An overview of the potential anticancer properties of cardamonin

Area of Science:

• Natural product chemistry
• Pharmacology
• Oncology

Background:

• Cancer remains a leading global cause of mortality, with existing treatments often causing severe side effects.
• Phytochemicals are increasingly investigated as potential anticancer agents due to their therapeutic properties and lower toxicity.
• Cardamonin, a chalcone from the *Alpinia* species, has demonstrated anti-cancer and anti-inflammatory activities.

Purpose of the Study:

• To review the chemo-preventive potential of cardamonin against various human malignancies.
• To summarize the anticancer mechanisms and therapeutic applications of cardamonin.

Main Methods:

• Preclinical studies utilizing *in vitro* cancer cell lines and *in vivo* xenograft mouse models.
• Analysis of cardamonin's effects on cancer cell proliferation, migration, invasion, and apoptosis.
• Investigation of key signaling pathways involved, including Wnt/β-catenin, NF-κB, and PI3K/Akt.

Main Results:

• Cardamonin exhibits anti-cancer effects against breast, lung, colon, and gastric cancer cell lines.
• The compound inhibits cancer cell proliferation, migration, and invasion while inducing apoptosis.
• Cardamonin demonstrates good biosafety and pharmacokinetic profiles, suggesting its potential as an anticancer drug.

Conclusions:

• Cardamonin is a promising natural therapeutic agent with significant anticancer properties.
• Its established mechanisms of action and favorable safety profile support its development as a novel anticancer drug.